BioTech

Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More

25 days ago   |   By Xconomy

Alexion Pharmaceuticals CEO Ludwig Hantson has made no secret that he wants to diversify his company's drug portfolio and he has shown willingness to open the corporate checkbook to accomplish that goal. Last October, Alexion struck a $930 million deal to acquire Achillion Pharmaceuticals , a biotech whose lead drug complements the Boston company's own therapies for rare blood diseases. This week, Alexion agreed to pay $1.4 billion for Portola Pharmaceuticals, whose main product treats emergency bleeding-not exactly a rare disease. It's a lot to pay for a drug that hasn't lived up to sales...
Read more ...

 


Search by Tags

   BioTech      Biotech      Pharmaceuticals      Pharmaceutical      Drug      Drugs      Therapies      Boston blog main      Boston top stories      Boulder      Denver blog main      Denver top stories      Detroit blog main      Detroit top stories      Europe blog main      Europe top stories      Indiana blog main      Indiana top stories      National      National blog main      National top stories      New York blog main      New York top stories      Raleigh-Durham blog main      Raleigh-Durham top stories      San Diego blog main      San Diego top stories      San Francisco blog main      San Francisco top stories      Seattle blog main      Seattle top stories      Texas blog main      Texas top stories      Wisconsin blog main      Wisconsin top stories      AbbVie      Achillion Pharmaceuticals      Akcea Therapeutics      Alexion Pharmaceuticals      Alnylam Pharmaceuticals      Andexanet alfa      Antibe Therapeutics      Apotex      Arrowhead Pharmaceuticals      AstraZeneca      Avrobio      Axcella Health. Newron Pharmaceuticals      Basal cell carcinoma      BioMarin Pharmaceutical      BioNtech      Blastic plasmacytoid dendritic cell neoplasm      Bristol-myers Squibb      Bruce Given      Cancer      Cardiff Oncology      Carla Poulson      Celgene      Cell Therapy      Cemiplimab      Censa Pharmaceuticals      Chemotherapy      Chlorambucil      Chronic Lymphocytic Leukemia      Clarametyx Biosciences      Clostridium difficile      COVID-19      CRISPR      Dapagliflozin      Diagnostics      DiNAQOR      Dry eye disease      Epilepsy      Federal Trade Commission      Ferring Pharmaceuticals      FogPharma      Fragile X Syndrome      Gemini Therapeutics      Gene Therapy      Gilead Sciences      Grail      Incyte      Innate Immune System      Investing      Joseph Stauffer      Kala Pharmaceuticals      Kezar Life Sciences      Kura Oncology      Life Sciences      Lisocaptagene maraleucel      Ludwig Hantson      Magenta Therapeutics      Marc Uknis      Mark Erlander      Menarini Group      Microbiome      Microbiome drugs      Myonexus Therapeutics      Neurological Diseases      Noreen Roth Henig      Novartis      Obinutuzumab      Ovid Therapeutics      Pfizer      Portola Pharmaceuticals      Pravastatin      Praxis Precision Medicines      PTC Therapeutics      Rare disease drugs      Rebiotix      Regeneron Pharmaceuticals      Remdesirvir      Rett syndrome      Sanofi      Sarepta Therapeutics      Sarizotan      Sherlock Biosciences      Startups      Stemline Therapeutics      Systolic heart failure      TG Therapeutics      Tony Gibney      TrovaGene      U.S. Department of Justice      Ublituximab      Umbralisib      Ventus Therapeutics      Vir Biotechnology  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

The World's Forests Are Growing Younger

The World's Forests Are Growing Younger

Researchers from Berkeley Lab and 20 other institutions have found that land use and atmospheric changes are altering forest structure around the world, resulting in fewer of... Read more ...

Smart Farms of the Future: Making Bioenergy Crops More Environmentally Friendly

Smart Farms of the Future: Making Bioenergy Crops More Environmentally Friendly

In a project led by Arva Intelligence, Berkeley Lab scientists will monitor carbon emissions and other indicators at five commercial farms in California and Arkansas. Farmers... Read more ...

Auditing Services - Data Integrity

Auditing Services - Data Integrity

Data integrity has become crucial to compliance for regulated life science companies. Data Integrity assures the completeness, consistency, accuracy, authenticity, timeliness... Read more ...

Webinar: Using SMRT Sequencing to Understand SARS-CoV-2 and the Host Immune...

Webinar: Using SMRT Sequencing to Understand SARS-CoV-2 and the Host Immune Response

As the flurry of research around the SARS-CoV-2 virus continues at an unprecedented pace, scientists are beginning to tackle some of the more complex immunological responses... Read more ...

Regeneron Pays Intellia $100M to Add Hemophilia to CRISPR R&D Pact

Regeneron Pays Intellia $100M to Add Hemophilia to CRISPR R&D Pact

Four years after Regeneron Pharmaceuticals and Intellia Therapeutics began working together to research the use of CRISPR/Cas9 to treat liver diseases, the partners are... Read more ...

Quality Control Technician

INOVIO Pharmaceuticals, Inc. is immediately seeking a full-time, temporary/contractor Quality Control Technician to work at the company's state-of-the-art manufacturing... Read more ...

Evofem Announces Proposed Public Offering of Common Stock

SAN DIEGO, June 2, 2020 /PRNewswire/ - Evofem Biosciences, Inc. , a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products... Read more ...

More efficient biosolar cells modelled on nature

Potential sources of renewable energy include protein complexes that are responsible for photosynthesis. However, their efficiency in technical applications still leaves much... Read more ...

Investigation on hydrodynamic lubrication of bearings in a left ventricular...

Abstract Formations of clots were found inside the hydrodynamic bearings of the left ventricular assisted devices and caused tremendous risks to the long-term use of these... Read more ...

Human Amnion Membrane Proteins Prevent Doxorubicin-Induced Oxidative Stress...

Abstract Doxorubicin is widely used as an effective chemotherapy agent in cancer treatment. Cardiac toxicity in cancer treatment with DOX demand urgent attention and no... Read more ...